Details for 2013752753

Up to date per 07.04.2026

Actions

Title / Product Name

BEHANDLUNG VON IMMUNBEDINGTEN ENTZÜNDUNGSERKRANKUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2013752753

EP Publication Number

2882441

E-Number

1262282

Language

PCT Number

US13054051

Publication Date

17.06.2015 A

29.04.2020 B1

Registration Date

29.04.2020

AT Publication Date

15.05.2020

Application Date

08.08.2013

Registration Number

Priorities

09.08.2012

201261681491 P

05.11.2012

201261722718 P

IPC

A61K 31/5355 20060101AFI20191024BHEP

Maximum Duration of Protection

08.08.2033

Owner

Celgene Corporation86 Morris Avenue Summit, NJ 07901US

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

SCHAFER, Peter, H.126 John E. Busch Avenue Somerset, NJ 08873US

CHOPRA, RajeshFlat 5, Ruvigny Mansions Putney Embankment London SW15 1LEGB

GANDHI, Anita37 Stirling Road Bernardsville, NJ 07924US

Information about Fees